Search

Lin Ying Liu

from Houston, TX
Age ~65

Lin Liu Phones & Addresses

  • Houston, TX
  • Rockville, MD
  • Bethesda, MD
  • Brooklyn, NY
  • Wheaton, MD

Professional Records

Medicine Doctors

Lin Liu Photo 1

Lin Liu

View page
Specialties:
Anatomic Pathology & Clinical Pathology
Education:
Medical School
Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71)
Graduated: 1986
Description:
Dr. Liu graduated from the Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71) in 1986. She works in Evanston, IL and specializes in Anatomic Pathology & Clinical Pathology. Dr. Liu is affiliated with Glenbrook Hospital, Highland Park Hospital, Northshore University Health System Evanston Hospital and Northshore University HealthSystem.

License Records

Lin Liu

License #:
23915 - Expired
Issued Date:
Jun 24, 2005
Renew Date:
Jun 1, 2012
Expiration Date:
Nov 30, 2013
Type:
Certified Public Accountant

Lin Ying Liu

Address:
Rockville, MD
License #:
1201115906 - Expired
Category:
Cosmetologist License
Issued Date:
Jan 10, 2011
Expiration Date:
Jan 31, 2015
Type:
Cosmetologist

Lin Y Liu

Address:
7979 Westheimer Rd APT 203, Houston, TX 77063
Phone:
(832) 416-6698
License #:
1630752 - Active
Category:
Cosmetology Operator
Expiration Date:
May 8, 2018

Resumes

Resumes

Lin Liu Photo 2

Lin Liu Silver Spring, MD

View page
Work:
Citibank

2011 to 2011
Member

Industrial and Commercial Bank of China

2011 to 2011
Financial Intern

Hefei University of Technology

2010 to 2010
Resident Assistant

Education:
Hefei University of Technology
2012
Bachelor of Economics in Finance

University of Wisconsin-Eau Claire
Eau Claire, WI
2012
Bachelor of Business Administration in Business Finance

Robert H. Smith School of Business, University of Maryland
College Park, MD
Master of Science in Business

Lin Liu Photo 3

Lin Liu College Park, MD

View page
Work:
DoubleL E-commerce Store

2013 to 2000
Co-founder/Procurement Director

Simulation Game

2013 to 2000
Co-manager/Senior Executive

Wall Street Standard Group
New York, NY
Jun 2013 to Aug 2013
Administrative /Research Assistant

Industrial and Commercial Bank of China

Jun 2011 to Sep 2011
Finance Intern

Citibank

Aug 2011 to Aug 2011
Finance Intern

Hefei University of Techonology

Jan 2009 to Jun 2009
Resident Assistant

Education:
Robert H. Smith School of Business, University of Maryland
College Park, MD
2012 to 2013
Master of Science in Business(MSB) in Supply Chain Management

Hefei University of Technology
2008 to 2012
Bachelor of Economics in Public Finance

University of Wisconsin-Eau Claire
Eau Claire, WI
2009 to 2011
Bachelor of Business Administration (BBA) in Finance

Skills:
Microsoft Office,Operation Management, Supply Chain Management, Inventory Management, Administration,Customer Service, Teamwork, Research Skill, ERP,SAP,Bloomberg

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dr. Lin Liu
Owner
Eastern Healing Center
Massage Therapists. Physical Therapists
1036 Portage Avenue, Winnipeg, MB R3G 0S2
(204) 284-4047
Lin Liu
Owner
Eastern Healing Center
Massage Therapists · Physical Therapists
(204) 284-4047
Lin L. Liu
Director, Owner
Liu Lin-Lin MD PA
Medical Doctor's Office
21216 NW Fwy, Cypress, TX 77429
Lin L. Liu
Manager
L.L.W. Holdings, LLC
Lin Liu
Manager
FENG TAI, LLC
Business Services at Non-Commercial Site · Nonclassifiable Establishments
3011 Auburn Path, Sugar Land, TX 77479
4211 Canterbury Ct, Sugar Land, TX 77479
Lin Liu
Director
IDIGGAPP INC
5103 Fld Briar Ln, Sugar Land, TX 77479
8743 Knight Rd, Houston, TX 77054
Lin Lin Liu
DirectorPresident
CYPRESS HEMATOLOGY/ONCOLOGY ASSOCIATES, PA
3730 Kirby Dr STE 600, Houston, TX 77098
Lin Lin Liu
DirectorPresident, Secretary, Treasurer, Vice-President
LIN-LIN LIU, M.D., PA
PO Box 9011, Spring, TX 77387

Publications

Us Patents

Vectors, Cells And Processes For Pyrimidine Deoxyribonucleosides Production

View page
US Patent:
6777209, Aug 17, 2004
Filed:
Mar 6, 2002
Appl. No.:
10/018878
Inventors:
David Martin Anderson - Rockville MD
Lin Liu - Rockville MD
Sergey Podkovyrov - Gaithersburg MD
Baomin Wang - Rockville MD
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C12N 120
US Classification:
435 87, 4353201, 435 691, 435325, 4352523, 435194, 435189, 435227, 43525233, 536 232, 530350
Abstract:
Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e. g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin or a uridine kinase gene and/or a dCTP deaminase gene. In preferred embodiments the constructs comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, the host cells comprise constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e. g.

Enzyme Treatment

View page
US Patent:
6780628, Aug 24, 2004
Filed:
Dec 8, 2000
Appl. No.:
09/731971
Inventors:
David M. Anderson - Rockville MD
Lin Liu - Rockville MD
Humg-Yu Hsiao - Rockville MD
Douglas W. Fodge - Derwood MD
Assignee:
Chemgen Corporation - Gaithersburg MD
International Classification:
A23L 131
US Classification:
435198, 435 4, 435 6, 435183, 435195, 426 2, 426 56, 426531
Abstract:
Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.

Vectors, Cells And Processes For Pyrimidine Deoxyribonucleosides Production

View page
US Patent:
7387893, Jun 17, 2008
Filed:
Aug 9, 2004
Appl. No.:
10/914529
Inventors:
David Martin Anderson - Rockville MD, US
Lin Liu - Rockville MD, US
Sergey Podkovyrov - Gaithersburg MD, US
Baomin Wang - Rockville MD, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C12N 15/00
C12N 1/20
C12N 5/10
C07H 21/00
C12N 9/02
C12N 9/12
C12N 9/78
C12Q 1/26
C12P 21/06
C07K 14/00
US Classification:
4353201, 4352523, 435325, 43525233, 435189, 435 25, 435 691, 435194, 435227, 536 232, 530350
Abstract:
Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e. g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin or a uridine kinase gene and/or a dCTP deaminase gene. In preferred embodiments the constructs comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, the host cells comprise constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e. g.

Composition Comprising Beta-Mannanase

View page
US Patent:
7723091, May 25, 2010
Filed:
May 28, 2004
Appl. No.:
10/855416
Inventors:
David M. Anderson - Rockville MD, US
Lin Liu - Rockville MD, US
Humg-Yu Hsiao - Rockville MD, US
Douglas W. Fodge - Derwood MD, US
Assignee:
Chemgen Corporation - Gaithersburg MD
International Classification:
C12N 9/24
C12N 9/00
C12Q 1/00
C12Q 1/68
A23L 1/31
C07H 21/04
US Classification:
435200, 426 58, 435 4, 435 6, 435 691, 435183, 530350, 536 232
Abstract:
Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.

Enzymes For Reduced Immunological Stress

View page
US Patent:
7914782, Mar 29, 2011
Filed:
Dec 14, 2006
Appl. No.:
11/610572
Inventors:
David M. Anderson - Rockville MD, US
Humg-Yu Hsiao - Rockville MD, US
Lin Liu - Rockville MD, US
Assignee:
Chemgen Corporation - Gaithersburg MD
International Classification:
A61K 38/47
US Classification:
424 9461
Abstract:
Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.

Biological Production Of Thymidine

View page
US Patent:
8263384, Sep 11, 2012
Filed:
Feb 5, 2007
Appl. No.:
12/278227
Inventors:
David Martin Anderson - Gaithersburg MD, US
Andrew John Collis - Ulverston, GB
Lin Liu - Gaithersburg MD, US
Sergey Podkovyrov - Gaithersburg MD, US
Christopher Preston - Ulverston, GB
Assignee:
Glaxo Group Limited - Greenford, Middlesex
International Classification:
C12N 1/21
C12P 19/38
US Classification:
4352523, 435189, 4353201, 435 87
Abstract:
Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e. g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e. g. T4 frd; Serine Hydroxymethyltransferase genes e. g. glyA; 3-phosphoglycerate dehydrogenase genes e. g. serA; and THF synthase genes e. g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.

Enzymes For Reduced Immunological Stress

View page
US Patent:
20110171344, Jul 14, 2011
Filed:
Mar 25, 2011
Appl. No.:
13/072109
Inventors:
DAVID M. ANDERSON - ROCKVILLE MD, US
HUMG-YU HSIAO - ROCKVILLE MD, US
LIN LIU - ROCKVILLE MD, US
International Classification:
A23K 1/165
US Classification:
426 2, 426 61
Abstract:
Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.

Enzymes For Reduced Immunological Stress

View page
US Patent:
20110171345, Jul 14, 2011
Filed:
Mar 25, 2011
Appl. No.:
13/072123
Inventors:
David M. Anderson - Rockville MD, US
Humg-Yu Hsiao - Rockville MD, US
Lin Liu - Rockville MD, US
International Classification:
A23K 1/165
US Classification:
426 2, 426 61
Abstract:
Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.
Lin Ying Liu from Houston, TX, age ~65 Get Report